New Four-in-One antibody takes on Hard-to-Treat cancers

NCT ID NCT04794972

First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 34 times

Summary

This early-phase study tests a new drug called GNC-039 in people with advanced solid tumors, including a type of brain cancer called glioma, that have come back or spread. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 60 adults will take part in this study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Cancer Hospital of Chongqing Medical University

    RECRUITING

    Chongqing, Chongqing Municipality, China

    Contact

    Contact

    Contact

    Contact

  • Beijing Tiantan Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 100070, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shenzhen Second People's Hospital

    RECRUITING

    Shenzhen, Guangdong, China

    Contact

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    RECRUITING

    Xian, Shanxi, China

    Contact

  • West China Hospital,Sichuan University

    RECRUITING

    Chengdu, Sichuan, China

    Contact

  • ZhuJiang Hospital of Southern Medical University

    RECRUITING

    Guangzhou, Guangdong, China

    Contact

Conditions

Explore the condition pages connected to this study.